{"data":{"ModuleTitle":{"label":"Module Title","value":"Company Description"},"CompanyName":{"label":"Company Name","value":"Neuraxis, Inc. Common Stock"},"Symbol":{"label":"Symbol","value":"NRXS"},"Address":{"label":"Address","value":"11550 NORTH MERIDIAN STREET,SUITE 325, CARMEL, Indiana, 46032, United States"},"Phone":{"label":"Phone","value":"(812) 689-0791"},"Industry":{"label":"Industry","value":null},"Sector":{"label":"Sector","value":null},"Region":{"label":"Region","value":null},"CompanyDescription":{"label":"Company Description","value":"NeurAxis, Inc. operates as a neuromodulation therapy device company in the United States. It offers IB-Stim, a percutaneous electrical nerve field stimulation system intended to be used in patients 11-18 years of age with functional abdominal pain associated with irritable bowel syndrome healthcare companies primarily hospitals and clinics. The company was formerly known as Innovative Health Solutions, Inc. and changed its name to NeurAxis, Inc. in March 2022. The company was founded in 2011 and is headquartered in Carmel, Indiana."},"CompanyUrl":{"label":"Company Url","value":null},"KeyExecutives":{"label":"Key Executives","value":[{"name":"Adrian Miranda","title":"Chief Medical Officer, SVP-Science & Technology"},{"name":"Brian Carrico","title":"President, Chief Executive Officer & Director"},{"name":"Gary Peterson","title":"Director, Director-Design & Engineering"}]}},"message":null,"status":{"rCode":200,"bCodeMessage":null,"developerMessage":null}}